W ITHIN recent years, public health laboratories have received an unprecedented number of requests for the laboratory diagnosis of specimens from patients with suspect infections incriminating members of the psittacosislymphogranuloma venereum ( LGV) group of viruses. Since most of the laboratories are not equipped to prepare their own psittacosis antigens for the performance of complement fixation (CF) tests, it has been necessary to rely upon commercially available sources for their supply. It has also been the practice, and at times the necessity, to substitute LGV for psittacosis CF antigens in tests on serums from cases of psittacosis on the basis that one is dealing with a group-specific antigen-antibody reaction. Meyer (1) concentration to one-fifth the original volume. Control antigen was prepared in the identical manner using normal embryonated eggs of the same age and batch.
Lygranum CF antigen was purchased from commercial sources, and the control antigen was the one accompanying the viral antigen.
The CF test for this study was that described by Sigel and co-workers (4). Both psittacosis and lygranum CF antigens were titrated by the block technique with ornithosis positive serum and two units used in the respective tests. Complement was added to the antigen-antibody system in a dosage of 1.8 to 2.0 units. All test serums were preliminarily absorbed with packed sheep erythrocytes and then inactivated at 560 C. for a period of 30 minutes before testing.
The psittacosis hemagglutinating antigen was also prepared from infected embryonated eggs. The infected allantoic fluid was centrifuged at 5,000 X gravity for 1 hour and the supernatant fluid, which served as the hemagglutinin, was stored at temperatures below -300 C. The hemagglutination-inhibition (HI) test was performed according to the method of Hilleman and co-workers (5, 6). All serums for this test were first absorbed with murine erythrocytes and then inactivated at 56' C. for 30 minutes.
Results
One hundred and six "negative" serums were selected to ascertain the ._-2n serums (87 percent) were taken from patients presenting a clinical history of, or exposure to, members of the psittacosis-LGV group of viruses (ornithosis and lymphogranuloma venereum). The results of the three serologic tests performed on the same serums are shown in tables 2, 3, and 4.
It is apparent from table 2 that psittacosis CF antigen was able to detect a larger number of positive serums than lygranum CF antigen. Ten of the serums (9.7 percent) showed some positive titer with psittacosis CF antigen when lygranum CF antigen was unable to react at the lowest dilution of serum tested (1: 2). Thirty-six (34.9 percent) of the serums elicited the same titer when tested with both CF antigens. Higher titers with psittacosis CF antigen were obtained with 61.2 percent of the serums as compared with lygranum CF antigen tested on the same serums, whereas only 3.9 percent of the serums gave higher titers with lygranum antigen. Public Health Reports Only 59 percent of the serums positive by both psittacosis CF and lygranum CF tests were also positive by the psittacosis HI test. With the current techniques employed, the psittacosis CF antigen reacts with a larger number of serums and in general gives hiigher titers than the lygranum CF antigen.
